To help bridge the gap between scientific discovery at academic-based institutions and commercial product development, the Brain Tumor Investment Fund (BTIF) is investing philanthropic capital to incentivize the progress of biotechnology, pharmaceutical, and medical device companies developing promising new treatment opportunities for patients with brain cancer.
The Brain Tumor Investment Fund is a growing and diverse venture philanthropy fund that leverages the National Brain Tumor Society’s (NBTS) 30 years of experience, expertise, and achievement. The fund will support NBTS’s vision to conquer and cure brain tumors by investing in biotechnology, pharmaceutical, and medical device companies developing products to improve the lives of brain tumor patients.
The Brain Tumor Investment Fund sparks private sector investment in brain tumor research and to create a robust and diverse market for drug development, while increasing the likelihood of success for companies bringing life-changing products to market.
Portfolio
Investment Strategy
Why Venture Philanthropy?